[Form 4] Confluent, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Confluent, Inc. (CFLT) reported an insider transaction. A company director exercised options, converted shares, and sold stock on 11/03/2025 under a pre-set Rule 10b5-1 plan.

The insider exercised 30,000 stock options at an exercise price of $2.24, received Class B shares, then converted 30,000 Class B into 30,000 Class A on a one-for-one basis. The insider then sold 30,000 Class A shares at an average price of $23.57, with trades ranging from $23.17 to $23.89.

Following these transactions, the insider held 28,549 Class A shares directly and 1,787 Class A shares indirectly via a trust. The option award referenced was fully vested.

Insights

Insider transactions analyst

Routine Form 4: option exercise, conversion, and planned sale.

An insider exercised 30,000 options at an exercise price of $2.24, received Class B shares, then converted them one-for-one into Class A. The sale of 30,000 Class A shares occurred under a Rule 10b5-1 plan, which can standardize trades and reduce discretion.

The average sale price was $23.57 with a disclosed range of $23.17–$23.89 on 11/03/2025. After the transactions, direct holdings were 28,549 Class A shares and 1,787 Class A held indirectly by a trust. Based on the routine nature of exercises, conversions, and plan sales, this reads as an administrative update.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Narkhede Neha

(Last) (First) (Middle)

C/O CONFLUENT, INC.

899 W. EVELYN AVENUE

(Street)

MOUNTAIN VIEW CA 94041

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Confluent, Inc. [ CFLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	11/03/2025		C		30,000	A	(1)	58,549	D
Class A Common Stock	11/03/2025		S		30,000(2)	D	$23.57(3)	28,549	D
Class A Common Stock								1,787	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.24	11/03/2025		M			30,000	(4)	10/21/2028	Class B Common Stock	30,000	$0	550,602	D
Class B Common Stock	(1)	11/03/2025		M		30,000		(1)	(1)	Class A Common Stock	30,000	$0	1,113,729	D
Class B Common Stock	(1)	11/03/2025		C			30,000	(1)	(1)	Class A Common Stock	30,000	$0	1,083,729	D

Explanation of Responses:

1. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock.

2. Shares sold pursuant to a 10b5-1 plan adopted June 10, 2025.

3. The shares were sold at prices ranging from $23.17 to $23.89 The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. Fully vested.

	/s/ Weilyn Wood, Attorney-in-Fact	11/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Confluent (CFLT) disclose in this Form 4?

An insider exercised 30,000 options at $2.24, converted 30,000 Class B to Class A, and sold 30,000 Class A shares on 11/03/2025.

Was the CFLT share sale made under a Rule 10b5-1 plan?

Yes. The filing notes sales were under a Rule 10b5-1 plan adopted on June 10, 2025.

What was the average and range of sale prices for CFLT shares?

The average sale price was $23.57, with trades ranging from $23.17 to $23.89.

How many Confluent (CFLT) shares did the insider hold after the sale?

Post-transaction, the insider held 28,549 Class A shares directly and 1,787 Class A shares indirectly via a trust.

What was the option exercise price and vesting status?

The options were exercised at $2.24 per share and were fully vested.

What is the conversion ratio between Confluent Class B and Class A shares?

Each Class B share converts into one Class A share, including upon sale or transfer and at the holder’s option.